• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Cell & Gene Therapy

FDA Building
Pharma

FDA removes barrier to CAR-Ts; move likely to boost uptake

The FDA removed the REMS requirements for currently approved BCMA- and CD19-directed CAR-T therapies and reduced certain post-infusion restrictions.
Angus Liu Jun 27, 2025 11:14am
FDA

FDA investigates 2 deaths after Sarepta Duchenne gene therapy

Jun 25, 2025 10:26am
Redbrick building with Sarepta name and logo

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Jun 16, 2025 10:58am
Robert F Kennedy Jr US President Donald Trumps nominee for Secretary of Health and Human Services testifies during hi
Favicon Fierce Biotech

At cell and gene roundtable, officials pledge to slash regulations

Jun 5, 2025 2:50pm
whale jumping out of water

Orca hires ex-Legend exec Gavel to target cell therapy market

Jun 5, 2025 11:58am
Collage poster study of businessmen picture chart arrow goes up

Novartis, Sarepta tipped to drive genomic therapy sales boom

May 15, 2025 12:18pm
More News

Bluebird investor reluctance pays off with better buyout offer

May 14, 2025 10:40am

Bluebird warns of potential bankruptcy amid buyout delay

May 13, 2025 9:56am

Sarepta sees delays in treatment after Elevidys death report

May 7, 2025 8:03am

As Pfizer bows out, CSL keeps hemophilia gene therapy hopes alive

Apr 11, 2025 10:32am
See more stories

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings